Clinical value of serum CA153，CA125，CEA combined detection in the diagnosis of breast cancer

YI Lin; LIU Xingming; LIN Ding; HUANG Xuemei; LIU Yu

您当前的位置：

首页 >

文章列表页 >

Clinical value of serum CA153，CA125，CEA combined detection in the diagnosis of breast cancer

更新时间：2023-12-18

- Clinical value of serum CA153，CA125，CEA combined detection in the diagnosis of breast cancer
- Journal of Chongqing Medical University Vol. 37, Issue 9, Pages: 802-805(2012)
- 作者机构：
  
  1. 重庆肿瘤研究所 1. 肿瘤学实验室
  2. 临检中心,重庆,400030
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2012，
扫描看全文
YI Lin, LIU Xingming, LIN Ding, et al. Clinical value of serum CA153，CA125，CEA combined detection in the diagnosis of breast cancer. [J]. Journal of Chongqing Medical University 37(9):802-805(2012)
DOI：

YI Lin, LIU Xingming, LIN Ding, et al. Clinical value of serum CA153，CA125，CEA combined detection in the diagnosis of breast cancer. [J]. Journal of Chongqing Medical University 37(9):802-805(2012) DOI：

摘要

目的：探讨血清糖类抗原（Carbohydrate antigen，CA）153、CA125、癌胚抗原（Carcinoembryonic antigen，CEA）联合检测在乳腺癌诊断中的临床价值。方法：采用化学发光微粒子免疫分析技术（Chemiluminescent microparticle immunoassay，CMIA）测定81例乳腺癌患者、55例乳腺良性疾病患者和67例健康女性血清中CA153、CA125、CEA的含量。结果：乳腺癌组的CA153、CA125、CEA水平和阳性率均显著高于乳腺良性疾病组和健康对照组（均P<0.05）；3项肿瘤标志物中，CA153阳性率最高（49.38%）；CA153、CA125、CEA联合检测的敏感性为69.14%，特异性为96.72%，准确度为85.71%，阴性预测值为82.52%，除特异性略有下降，其余指标均高于单项检测。Ⅰ、 Ⅱ期乳腺癌患者CA153单项检测的阳性率（15.91%）明显低于Ⅲ、Ⅳ期患者（89.19%），CA153、CA125、CEA联合检测显著提高了各期乳腺癌患者诊断的阳性率（Ⅰ、 Ⅱ期：47.73%，Ⅲ、Ⅳ期：94.59%）。CA153、CA125、CEA的受试者工作特征（Receiver operating characteristic，ROC）曲线下面积分别为0.774、0.664、0.690，联合检测的ROC曲线下面积为0.807。结论：单项肿瘤标志物检测在乳腺癌的早期诊断中应用价值不高。CA153、CA125和CEA联合检测有助于提高乳腺癌的诊断性能和早期检出率，有助于乳腺癌和乳腺良性病变的鉴别诊断，3项联合检测是检查乳腺癌较为理想的标志物组合。

Abstract

Objective：To evaluate the clinical value of serum carbohydrate antigen（CA）153，CA125，carcinoembryonic antigen（CEA） combined detection in the diagnosis of breast cancer. Methods：Chemiluminescent microparticle immunoassay（CMIA） was used to detect the serum levels of CA153，CA125，CEA in 81 patients with breast cancer，55 patients with benign breast diseases and 67 healthy women. Results：The levels and positive rates of CA153，CA125 and CEA in patients with breast cancer were significantly higher than those in patients with benign breast diseases and healthy controls（P<0.05）. The positive rate of CA153（49.38%） was the highest among three tumor markers. The sensitivity，specificity，accuracy and negative predictive values of combined detection of CA153，CA125 and CEA were 69.14%，96.72%，85.71% and 82.52%，respectively. The value of specificity in combined detection was decreased slightly，while the values of other indicators were higher in combined detection than in single detection. The positive rate of CA153 was obviously lower in breast cancer patients at stage Ⅰ and Ⅱ（15.91%） than in those at stage Ⅲ and Ⅳ（89.19%）. The combined detection of CA153，CA125 and CEA greatly improved the positive rates for breast cancer patients at different clinical stages（stageⅠ and Ⅱ：47.73%，stage Ⅲ and Ⅳ：94.59%）. The area under receiver operating characteristic（ROC） curves of CA153，CA125 and CEA was 0.774，0.664 and 0.690 respectively. The area under ROC curves of the combined detection was 0.807. Con－clusions：The clinical value of single tumor marker detection in the early diagnosis of breast cancer is limited. The combined detec－tion of CA153，CA125 and CEA is beneficial to improving the diagnosis performance as well as to increasing the early diagnosis rate for breast cancer. In addition，it is helpful to the differential diagnosis between breast cancer and benign breast diseases. The combined detection of CA153，CA125 and CEA is an ideal marker combination in the detection of breast cancer.

关键词

乳腺癌糖类抗原153糖类抗原125癌胚抗原联合检测

Keywords

breast cancercarbohydrate antigen 153carbohydrate antigen 125carcinoembryonic antigencombined detection

references

Views

1143

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Pathomics signature based on machine learning can predict the response to neoadjuvant chemotherapy in breast cancer patients

The clinical value of serum HE4, CA125 and CA199 in identifying the myometrial invasion depth and pathological stage of uterine corpus endometrial carcinoma

Effects of circular RNA hsa_circ_0002185 on cell viability and invasion of breast cancer cells and its mechanism of action

Prediction and identification of H-2Kd restricted CTL epitope derived from breast cancer associated antigen ROR1

Comparison of lung dosimetry between supine and sternal horizon positions during X-ray irradiated radical mastectomy radiation therapy

Related Author

Zhang Jieqiu

Wu Qi

Wang Jianmei

Yao Xiaopeng

Wang Na

Guo Yunfeng

Song Liqin

Ma Junying

Related Institution

Department of Epidemiology and Health Statistics， School of Public Health，Southwest Medical University

Department of Pathology，The Affiliated Hospital of Southwest Medical University

Department of Medical Engineering Technology，School of Medical Information and Engineering，Southwest Medical University

Department of Gynecology, The Fourth Hospital of Hebei Medical University

Department of gynecology and oncology, The Fourth Hospital of Hebei Medical University

⁰